Boehringer Ingelheim Latest to Sue over Medicare Drug Negotiation Program
- August 25, 2023
Boehringer Ingelheim Pharmaceuticals, Inc. added August 18 another lawsuit to the mounting challenges seeking to block the new Medicare drug price negotiation program.
ARTICLE TAGS
You must be logged in to access this content.